Search For "pharmaceutical major zydus"
DCGI examining Zydus Cadila's COVID vaccine for children, says Dr VK Paul
Updated : 4 years, 8 months ago IST
New Delhi [India], July 16 (ANI): Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
Read More
Zydus Cadila's COVID vaccines for children may be available in near future
Updated : 4 years, 8 months ago IST
New Delhi [India], July 16 (ANI): Pharmaceutical major Zydus Cadila's COVID-19 vaccine may be available in the near future for children in the age group of 12 to 18 years, the Centre in an affidavit told the Delhi High Court on Friday.
Read More
Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccin
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their ZyCoV-D vaccine for 12 years and above, sources said .
Read More
Zydus Cadila likely to seek emergency authorisation for ZyCoV-D COVID-19 v
Updated : 4 years, 9 months ago IST
New Delhi [India], June 18 (ANI): Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the next seven-eight days.
Read More
Zydus Cadila Q4 net profit up 73 pc at Rs 679 crore
Updated : 4 years, 9 months ago IST
Ahmedabad (Gujarat) [India], May 27 (ANI): Pharmaceutical major Zydus Cadila said on Thursday its net profit jumped 73 per cent year-on-year to Rs 679 crore during the quarter ended March.
Read More
Zydus Cadila to sell one animal health business for Rs 2,921 crore
Updated : 4 years, 10 months ago IST
Ahmedabad (Gujarat) [India], May 12 (ANI): Pharmaceutical major Zydus Cadila said on Wednesday it has signed agreements to sell one of its animal health business companies to Multiples Alternate Asset Management led consortium for Rs 2,921 crore.
Read More
Zydus Cadila's net profit up 41 pc in Q3 to Rs 527 crore
Updated : 5 years, 1 month ago IST
Ahmedabad (Gujarat) [India], February 5 (ANI): Pharmaceutical major Zydus Cadila said on Friday its profit after tax was up by 41 per cent to Rs 527 crore in Q3 FY21 as compared to the corresponding quarter of previous year.
Read More
At Rs 2,800, Zydus launches Remdac for treatment of COVID-19 in India
Updated : 5 years, 7 months ago IST
Ahmedabad (Gujarat) [India], Aug 13 (ANI): Pharmaceutical major Zydus Cadila said on Thursday it has launched Remdesivir under the brand name Remdac for treatment of COVID-19 in the Indian market.
Read More
Zydus gets Mexican regulator nod to conduct clinical trials with Pegylated
Updated : 5 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 17 (ANI): Pharmaceutical major Zydus said on Friday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to conduct clinical trials with its biological therapy 'Pegylated Interferon alpha-2b' for the treatm
Read More
Zydus begins human trials for potential COVID-19 vaccine
Updated : 5 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 15 (ANI): Pharmaceutical major Zydus on Wednesday started human clinical trials of its plasmid DNA vaccine ZyCoV-D -- a potential COVID-19 vaccine.
Read More
Zydus gets Mexican regulator nod for Desidustat in test management of COVI
Updated : 5 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 6 (ANI): Pharmaceutical major Zydus Cadila said on Monday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its one of its lead research candidate Desidustat to be tested in the management of COVID-1
Read More